We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
Cap. Flow
-$880M
Cap. Flow %
-3.82%
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$63.2M
2
EXP icon
Eagle Materials
EXP
+$56.2M
3
ITRI icon
Itron
ITRI
+$54.4M
4
AAPL icon
Apple
AAPL
+$52.6M
5
ENPH icon
Enphase Energy
ENPH
+$40.6M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$82.8M
2
NVDA icon
NVIDIA
NVDA
+$76M
3
MSFT icon
Microsoft
MSFT
+$62.6M
4
ADBE icon
Adobe
ADBE
+$62.2M
5
JBL icon
Jabil
JBL
+$41M

Sector Composition

Rank Sector Weight
1 Technology 36.79%
2 Healthcare 19.28%
3 Financials 10.14%
4 Communication Services 9.05%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYGN icon
1076
Myriad Genetics
MYGN
$303M
$592K ﹤0.01%
24,188
+2,000
+9% +$43.9K
BXMT icon
1077
Blackstone Mortgage Trust
BXMT
$2.44B
$591K ﹤0.01%
33,951
+5,600
+20% +$101K
FHI icon
1078
Federated Hermes
FHI
$4.74B
$590K ﹤0.01%
17,953
BLKB icon
1079
Blackbaud
BLKB
$2.1B
$589K ﹤0.01%
7,730
UCB
1080
United Community Banks
UCB
$4.43B
$589K ﹤0.01%
23,139
UE icon
1081
Urban Edge Properties
UE
$2.78B
$587K ﹤0.01%
31,790
LCID icon
1082
Lucid Motors
LCID
$2.54B
$585K ﹤0.01%
22,410
+10,362
+86% +$277K
ADT icon
1083
ADT
ADT
$5.46B
$584K ﹤0.01%
76,900
NTLA icon
1084
Intellia Therapeutics
NTLA
$1.66B
$584K ﹤0.01%
26,100
+7,100
+37% +$169K
NUVL
1085
DELISTED
Nuvalent
NUVL
$584K ﹤0.01%
7,700
+2,300
+43% +$164K
PLXS icon
1086
Plexus
PLXS
$7.04B
$582K ﹤0.01%
5,637
EDR
1087
DELISTED
Endeavor Group Holdings, Inc.
EDR
$581K ﹤0.01%
21,500
-10,900
-34% -$290K
OUT icon
1088
Outfront Media
OUT
$5.24B
$580K ﹤0.01%
41,231
VLY icon
1089
Valley National Bancorp
VLY
$8.3B
$580K ﹤0.01%
83,087
-7,700
-8% -$56.2K
FROG icon
1090
JFrog
FROG
$11.5B
$578K ﹤0.01%
15,400
+1,200
+8% +$44K
FTDR icon
1091
Frontdoor
FTDR
$5.83B
$578K ﹤0.01%
17,100
+100
+0.6% +$3.37K
EXTR icon
1092
Extreme Networks
EXTR
$3.16B
$576K ﹤0.01%
42,800
+18,800
+78% +$216K
RXO icon
1093
RXO
RXO
$3.85B
$575K ﹤0.01%
22,000
+3,000
+16% +$62.4K
AMED
1094
DELISTED
Amedisys
AMED
$574K ﹤0.01%
6,251
OPLN
1095
Openlane
OPLN
$4.33B
$573K ﹤0.01%
34,525
+8,300
+32% +$142K
VCEL icon
1096
Vericel Corp
VCEL
$2.28B
$573K ﹤0.01%
12,479
+400
+3% +$18.9K
HUBG icon
1097
HUB Group
HUBG
$2.55B
$572K ﹤0.01%
13,288
MNSO icon
1098
MINISO
MNSO
$3.53B
$572K ﹤0.01%
+30,000
New +$661K
AX icon
1099
Axos Financial
AX
$5.72B
$571K ﹤0.01%
9,995
ASB icon
1100
Associated Banc-Corp
ASB
$6.07B
$570K ﹤0.01%
26,962

Similar funds

Handelsbanken Fonder's Q2 2024 Portfolio in Review

As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.

  • Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
  • Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
  • Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
  • Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
  • Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
  • Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
  • Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.

Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.